A Survey of Antidepressant Prescribing Practices in Major Depression with Comorbid Attention-Deficit Hyperactivity Disorder

[1]  S. Faraone,et al.  Meta-Analysis of the Efficacy of Methylphenidate for Treating Adult Attention-Deficit/Hyperactivity Disorder , 2004, Journal of clinical psychopharmacology.

[2]  J. Biederman,et al.  Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. , 2002, The Journal of clinical psychiatry.

[3]  S. Faraone,et al.  A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder. , 2002, Archives of general psychiatry.

[4]  M. Fava,et al.  A survey of prescribing practices in the treatment of depression , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[5]  C. Nemeroff,et al.  Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. , 2001, The American journal of psychiatry.

[6]  M. Monuteaux,et al.  A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. , 2001, The American journal of psychiatry.

[7]  J. Swanson,et al.  A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[8]  Allan Reiss,et al.  Bupropion hydrochloride in attention deficit disorder with hyperactivity. , 1996, Journal of the American Academy of Child and Adolescent Psychiatry.

[9]  M. D. Banov,et al.  A double-blind trial of bupropion versus desipramine for bipolar depression. , 1994, The Journal of clinical psychiatry.

[10]  M. Peet.  Induction of Mania with Selective Serotonin Re-uptake Inhibitors and Tricyclic Antidepressants , 1994, British Journal of Psychiatry.

[11]  J. Kane,et al.  Extending indications for long-term pharmacotherapy: opportunities and challenges. , 2002, The American journal of psychiatry.

[12]  J. Biederman,et al.  A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder. , 2000, Journal of child and adolescent psychopharmacology.

[13]  R. Findling.  Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series. , 1996, Journal of child and adolescent psychopharmacology.

[14]  R. Olvera,et al.  An open trial of venlafaxine in the treatment of attention-deficit/hyperactivity disorder in children and adolescents. , 1996, Journal of child and adolescent psychopharmacology.

[15]  O. Devinsky,et al.  Open-label trial of venlafaxine in adults with attention deficit disorder. , 1995, Psychopharmacology bulletin.